Evaluation of Blood Pressure Monitor With AFib Screening Feature

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 574 participants.

Also called NCT05599308

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 574 participants (enrolled count) (from the registry)
Sponsor
  • ICON plc Registry lists this organization as a collaborator
Registry
  • NCT NCT05599308
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05599308. Non-randomized; no masking; primary purpose screening. Start 2022-09-06 (actual); primary completion 2023-04-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Blood Pressure Monitor With AFib Screening Feature
Intervention (Device)
OMRON blood pressure monitor with AFib (atrial fibrillation) screening feature
Intervention (Device)
Microlife WatchBP Home A
Lead sponsor
Omron Healthcare Co., Ltd. (class: industry)
Collaborator
ICON plc (class: industry)

Record details

Record id
cardio:ct-nct05599308
Content hash
cd53a090b0610a13f3330e9af4252c6b5d1648c6b48409e7fcd7e39d3dc7392a